Copyright Reports & Markets. All rights reserved.

Global Personalized Psychiatry Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Personalized Psychiatry by Type
    • 1.3.1 Overview: Global Personalized Psychiatry Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Personalized Psychiatry Consumption Value Market Share by Type in 2025
    • 1.3.3 Depression and Anxiety
    • 1.3.4 Bipolar Disorder
    • 1.3.5 Addiction
    • 1.3.6 Other
  • 1.4 Global Personalized Psychiatry Market by Application
    • 1.4.1 Overview: Global Personalized Psychiatry Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Mental Health Professionals
    • 1.4.3 Patients
    • 1.4.4 Healthcare Providers
  • 1.5 Global Personalized Psychiatry Market Size & Forecast
  • 1.6 Global Personalized Psychiatry Market Size and Forecast by Region
    • 1.6.1 Global Personalized Psychiatry Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Personalized Psychiatry Market Size by Region, (2021-2032)
    • 1.6.3 North America Personalized Psychiatry Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Personalized Psychiatry Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Personalized Psychiatry Market Size and Prospect (2021-2032)
    • 1.6.6 South America Personalized Psychiatry Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Personalized Psychiatry Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 COMPASS Pathways
    • 2.1.1 COMPASS Pathways Details
    • 2.1.2 COMPASS Pathways Major Business
    • 2.1.3 COMPASS Pathways Personalized Psychiatry Product and Solutions
    • 2.1.4 COMPASS Pathways Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 COMPASS Pathways Recent Developments and Future Plans
  • 2.2 Mindstrong Health
    • 2.2.1 Mindstrong Health Details
    • 2.2.2 Mindstrong Health Major Business
    • 2.2.3 Mindstrong Health Personalized Psychiatry Product and Solutions
    • 2.2.4 Mindstrong Health Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mindstrong Health Recent Developments and Future Plans
  • 2.3 Pear Therapeutics
    • 2.3.1 Pear Therapeutics Details
    • 2.3.2 Pear Therapeutics Major Business
    • 2.3.3 Pear Therapeutics Personalized Psychiatry Product and Solutions
    • 2.3.4 Pear Therapeutics Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pear Therapeutics Recent Developments and Future Plans
  • 2.4 Cogito
    • 2.4.1 Cogito Details
    • 2.4.2 Cogito Major Business
    • 2.4.3 Cogito Personalized Psychiatry Product and Solutions
    • 2.4.4 Cogito Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cogito Recent Developments and Future Plans
  • 2.5 Kaia Health
    • 2.5.1 Kaia Health Details
    • 2.5.2 Kaia Health Major Business
    • 2.5.3 Kaia Health Personalized Psychiatry Product and Solutions
    • 2.5.4 Kaia Health Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Kaia Health Recent Developments and Future Plans
  • 2.6 Sooma
    • 2.6.1 Sooma Details
    • 2.6.2 Sooma Major Business
    • 2.6.3 Sooma Personalized Psychiatry Product and Solutions
    • 2.6.4 Sooma Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sooma Recent Developments and Future Plans
  • 2.7 GenoMind
    • 2.7.1 GenoMind Details
    • 2.7.2 GenoMind Major Business
    • 2.7.3 GenoMind Personalized Psychiatry Product and Solutions
    • 2.7.4 GenoMind Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GenoMind Recent Developments and Future Plans
  • 2.8 Empatica
    • 2.8.1 Empatica Details
    • 2.8.2 Empatica Major Business
    • 2.8.3 Empatica Personalized Psychiatry Product and Solutions
    • 2.8.4 Empatica Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Empatica Recent Developments and Future Plans
  • 2.9 Akili Interactive
    • 2.9.1 Akili Interactive Details
    • 2.9.2 Akili Interactive Major Business
    • 2.9.3 Akili Interactive Personalized Psychiatry Product and Solutions
    • 2.9.4 Akili Interactive Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Akili Interactive Recent Developments and Future Plans
  • 2.10 Neuroverse
    • 2.10.1 Neuroverse Details
    • 2.10.2 Neuroverse Major Business
    • 2.10.3 Neuroverse Personalized Psychiatry Product and Solutions
    • 2.10.4 Neuroverse Personalized Psychiatry Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Neuroverse Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Personalized Psychiatry Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Personalized Psychiatry by Company Revenue
    • 3.2.2 Top 3 Personalized Psychiatry Players Market Share in 2025
    • 3.2.3 Top 6 Personalized Psychiatry Players Market Share in 2025
  • 3.3 Personalized Psychiatry Market: Overall Company Footprint Analysis
    • 3.3.1 Personalized Psychiatry Market: Region Footprint
    • 3.3.2 Personalized Psychiatry Market: Company Product Type Footprint
    • 3.3.3 Personalized Psychiatry Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Personalized Psychiatry Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Personalized Psychiatry Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Personalized Psychiatry Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Personalized Psychiatry Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Personalized Psychiatry Consumption Value by Type (2021-2032)
  • 6.2 North America Personalized Psychiatry Market Size by Application (2021-2032)
  • 6.3 North America Personalized Psychiatry Market Size by Country
    • 6.3.1 North America Personalized Psychiatry Consumption Value by Country (2021-2032)
    • 6.3.2 United States Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Personalized Psychiatry Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Personalized Psychiatry Consumption Value by Type (2021-2032)
  • 7.2 Europe Personalized Psychiatry Consumption Value by Application (2021-2032)
  • 7.3 Europe Personalized Psychiatry Market Size by Country
    • 7.3.1 Europe Personalized Psychiatry Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 7.3.3 France Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Personalized Psychiatry Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Personalized Psychiatry Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Personalized Psychiatry Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Personalized Psychiatry Market Size by Region
    • 8.3.1 Asia-Pacific Personalized Psychiatry Consumption Value by Region (2021-2032)
    • 8.3.2 China Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 8.3.5 India Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Personalized Psychiatry Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Personalized Psychiatry Consumption Value by Type (2021-2032)
  • 9.2 South America Personalized Psychiatry Consumption Value by Application (2021-2032)
  • 9.3 South America Personalized Psychiatry Market Size by Country
    • 9.3.1 South America Personalized Psychiatry Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Personalized Psychiatry Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Personalized Psychiatry Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Personalized Psychiatry Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Personalized Psychiatry Market Size by Country
    • 10.3.1 Middle East & Africa Personalized Psychiatry Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Personalized Psychiatry Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Personalized Psychiatry Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Personalized Psychiatry Market Drivers
  • 11.2 Personalized Psychiatry Market Restraints
  • 11.3 Personalized Psychiatry Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Personalized Psychiatry Industry Chain
  • 12.2 Personalized Psychiatry Upstream Analysis
  • 12.3 Personalized Psychiatry Midstream Analysis
  • 12.4 Personalized Psychiatry Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Personalized Psychiatry market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Personalized Psychiatry market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Personalized Psychiatry market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Personalized Psychiatry market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Personalized Psychiatry market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Personalized Psychiatry market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Personalized Psychiatry
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Personalized Psychiatry market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica, Akili Interactive, Neuroverse, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Personalized Psychiatry market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Depression and Anxiety
    Bipolar Disorder
    Addiction
    Other
    Market segment by Application
    Mental Health Professionals
    Patients
    Healthcare Providers
    Market segment by players, this report covers
    COMPASS Pathways
    Mindstrong Health
    Pear Therapeutics
    Cogito
    Kaia Health
    Sooma
    GenoMind
    Empatica
    Akili Interactive
    Neuroverse
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Personalized Psychiatry product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Personalized Psychiatry, with revenue, gross margin, and global market share of Personalized Psychiatry from 2021 to 2026.
    Chapter 3, the Personalized Psychiatry competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Personalized Psychiatry market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Psychiatry.
    Chapter 13, to describe Personalized Psychiatry research findings and conclusion.

    Buy now